Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dionysos cohort

Gut

Volumn 45, Issue 3, 1999, Pages 435-441

  Lenzi, M ^a,b   Bellentani, S ^c   Saccoccio, G ^c   Muratori, P ^a   Masutti, F ^c   Muratori, L ^a   Cassani, F ^a   Bianchi, F B ^a   Tiribelli, C ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c NONE

Author keywords

Chronic liver disease; Cohort study; Hepatitis C virus genotypes; Non organ specific autoantibodies; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CASE CONTROL STUDY; CHRONIC LIVER DISEASE; COHORT ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL;

EID: 0032775885     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.3.435     Document Type: Article

References (40)

1. 1 Lenzi M, Johnson PJ, McFarlane IG, et al. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991;338:277-80.
2. 2 Cassani F, Muratori L, Manotti P, et al. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut 1993;33:1260-3.
3. 3 Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-64.
4. 4 Fried MW, Draguesku JO, Shindo M, et al. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 1993;38:631-6.
5. 5 Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-19.
6. 6 Meyer zum Buschenfelde KH, Lohse AW, Gerken G, et al. The role of autoimmunity in hepatitis C infection. J Hepatol 1995;22(suppl 1):93-6.
7. 7 Czaja AJ, Carpenter HA, Santrach PJ, et al. Evidence aganst hepatitis viruses as inportant causes of severe autoimmune hepatitis in the united States. J Hepatol 1993;18:342-52.
8. 8 Reddy KR, Krawitt EL, Homberg JC, et al. Absence of LKM1 antibody in hepatitis C viral infection in the United States. J Viral Hepat 1995;2:175-9.
9. 9 Lunel F, Abuaf N, Frangeul L, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992;16:630-6.
10. 10 Czaja, AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adult with cronic hepatitis. Gastroenterology 1992;103: 1290-5.
11. 11 Ferri C, Greco F, Longobardo G, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-10.
12. 12 Lunel F, Musset L, Franjeul L, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
13. 11 Cacoub P, Lunel-Fabiani F, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
14. 14 Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
15. 15 Tran A, Quaranta JF, Benzaken S, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993;18:253-7.
16. 16 Johnson JR, Gretch DR, Yamabe H, et al. Menbranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
17. 17 Pawlotsky JM, Ben Hayia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-8.
18. 18 Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialoadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
19. 19 Adinolfi LE, Utili R, Attanasio V, et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996;28:1-9.
20. 20 Wong VS, Egner W, Elsey T, et al. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
21. 21 Muratori L, Gibellini D, Lenzi M, et al. Quantification of hepatitis C. virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1997;88:2768-74.
22. 22 Czaja AJ, Herschel A, Carpenter A, et al. Immunological features and HLA association in chronic viral hepatitis. Gastroenterology 1995;108:157-64.
23. 23 Ruiz-Moreno M, Rua MJ, Carreno V, et al. Autoimmune chronic hepatitis type 2 manifested during interferon therapy in children. J Hepatol 1991;12:265-6.
24. 24 Papo T, Marcellin P, Bernuau J, et al. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 1992;116:51-3.
25. 25 Muratori L, Lenzi M, Cataleta M, et al. Interferon therapy in liver/kidney microsomal antibidy type 1-positive patients with chronic hepatitis C. J Hepatol 1994;21:199-203.
26. 26 Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology 1994;20:1442-9.
27. 27 Block G, Hartmann AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
28. 28 Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673-9.
29. 29 Johnson PJ, McFarlane IG (convenors on behalf of the panel). Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005.
30. 30 Cassani F, Bianchi FB, Lenzi M, et al. Immunomorphological characterization of antinuclear antibodies in chronic liver disease. J Clin Pathol 1985;38:801-5.
31. 31 Bottazzo GF, Florin-Christensen A, Fairfax A, et al. Classification of smooth muscle autoantibodies (SMA) detected by immunofluorescence. J Clin Pathol 1976;29:403-10.
32. 32 Cassani F, Fusconi M, Bianchi FB, et al. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol 1987;68:588-95.
33. 33 Meier P, Beach M. Biostatistics for the clinician. In: Chalmers TC, ed. Data analysis for clinical medicine. Rome: International University Press, 1988:7-29.
34. 34 Fleiss JL. Statistical methods for rates and proportions. New York: Wiley and Sons, 1981:82-99.
35. 35 Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: John Wiley, 1989.
36. 36 Czaja AJ, Carpenter HA, Santrach PJ, et al. Immunologic features and HLA association in chronic viral hepatitis. Gastroenterology 1995;108:157-64.
37. 37 Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6.
38. 38 Holborow EJ, Hemsted EH, Mead SV. Smooth muscle autoantibodies in infectious mononucleosis. BMJ 1973;3: 323-5.
39. 39 Pedersen JS, Toh BH, Mackay IR, et al. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol 1982;48:527-32.
40. 40 Cassani F, Tremolada F, Baffoni L, et al. Markers of "viral" autoimmunity in chronic non-A, non-B post-transfusion hepatitis. Ital J Gastroenterol 1988;20:171-4.